Nivolumab is a safe and effective treatment of NSCLC
Crossref DOI link: https://doi.org/10.1038/nrclinonc.2015.48
Published Online: 2015-03-10
Published Print: 2015-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Text and Data Mining valid from 2015-03-10
Article History
First Online: 10 March 2015